Clinical trials
Metabolism clinical trials
Below are recruiting metabolism clinical trials, each written for real people, not researchers. We’re tracking 1,077 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01780168Recruiting
Study of metabolism, infection, and immunity in mitochondrial disease
This study looks at how metabolism, infections, and the immune system work together in people with mitochondrial disease. It aims to learn more about the condition and may help guide future treatments.
Bethesda, MarylandAges 4 weeks–115 years - NCT06232889Recruiting
Imaging study to check liver tumor response to radiation treatment
This study uses special MRI scans and PET scans to see how liver tumors respond to a radiation treatment called radioembolization (SIRT). The goal is to improve how treatment response is measured in people with metastatic liver disease.
UtrechtAges 18 years+ - NCT05400733Recruiting
Study of how your body handles meals in older adults
This study looks at your “meal response”—how your blood sugar and related body processes change after eating. It may help researchers understand different metabolic patterns and how to improve health or treatment strategies for older adults.
College Station, TexasAges 60–80 - NCT07747259Recruiting
Core stability and quality of life in active women with polyendocrine metabolic ovarian syndrome
This study compares core stability, body awareness, pelvic health, sleep, and quality of life between physically active women with and without polyendocrine metabolic ovarian syndrome (PMOS). It aims to understand how this condition affects these areas, which may help guide future treatments.
IstanbulAges 18–40 - NCT07165028RecruitingPhase 3
Study of new drugs for fatty liver with scarring
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
Tuscaloosa, AlabamaAges 18 years+ - NCT07288138RecruitingPhase 2
Study of a New Drug for MASH (Fatty Liver Disease)
This study is testing a new drug that targets thyroid hormone receptors in the liver, alone or combined with another drug, to reduce inflammation and scarring in people with MASH (a type of fatty liver disease). If you have MASH with moderate liver scarring and are otherwise healthy, this trial may help find a new treatment option.
Chandler, ArizonaAges 18–75 - NCT06930976Recruiting
Tracing sugar use in immune cells
This study uses a special sugar (glucose) to see how your immune cells use energy. You drink a labeled sugar, then give blood samples so researchers can track it.
Nashville, TennesseeAges 18 years+ - NCT06867419Recruiting
Metabolic effects on fatty liver disease score
This study looks at how certain features of your metabolism affect a simple score (called the FAST score) in people with fatty liver disease (MASLD). It aims to help doctors better understand and manage the condition.
Tanta, GharbyeaAges 18 years+ - NCT06647368Recruiting
Measuring brain sugar use with glucagon
This study tests a new way to measure how the brain uses sugar (glucose) to see if the hormone glucagon affects it. It may help researchers understand how certain hormones work in the body.
CopenhagenAges 25–70 - NCT06506513Recruiting
Can exercise help fatty liver disease?
This study tests whether a program of physical activity can reduce fat in the muscles and liver of people with MASLD, a type of fatty liver disease linked to metabolism. It looks at how exercise might help improve liver health.
BrusselsAges 18–70 - NCT06053294Recruiting
Brain and metabolism study on carbohydrate reward
This study looks at how brain responses and metabolism affect your desire for carbohydrates. Volunteers have MRI scans and taste tests at the Fralin Biomedical Research Institute in Roanoke.
Roanoke, VirginiaAges 18–45 - NCT03849963Recruiting
Brain imaging study of energy use and brain chemicals
This study uses MRI scans to measure how your brain uses energy and how certain brain chemicals are made. It’s for healthy adults and can help researchers understand normal brain chemistry and metabolism.
Dallas, TexasAges 18–60 - NCT07431723Recruiting
Magnetic magnets to connect the intestines during surgery
This trial is testing a new way to connect parts of the large or small intestine using magnets instead of staples or stitches. It may help people who need certain types of colon or rectal surgery recover with less pain and fewer complications.
SantiagoAges 18–75 - NCT06961773Enrolling by invitation
Bone health in young female runners
This study looks at how running affects bone health in young women. If you're a premenopausal woman who runs regularly, researchers want to understand your bone metabolism better.
Madrid, Comunity of MadridAges 18–30 - NCT06012227Recruiting
Cheese and metabolic health in middle age
This study looks at how eating cheese affects your body's ability to use energy (metabolic flexibility). It is for healthy middle-aged adults who are not overweight and do not have metabolic conditions like diabetes.
Monserrato, CagliariAges 45–65 - NCT07090083Recruiting
Liver health and food support for children
This study tests whether providing fruit and vegetable vouchers to families with children who have fatty liver disease can improve liver health. Diet and lifestyle are key to managing this condition.
San Francisco, CaliforniaAges 6–17 - NCT05669742RecruitingPhase 3
Empagliflozin plus olanzapine to reduce metabolic side effects
This trial tests whether adding empagliflozin to standard olanzapine treatment can improve metabolic problems (like blood sugar and cholesterol changes) that can happen with olanzapine in people with schizophrenia. If you qualify, you would be closely monitored for benefits and side effects.
TantaAges 18–65 - NCT07491458RecruitingPhase 2
Study of HU6 versus placebo for adults with MASH
This trial tests if HU6 is safe and effective for people with MASH, a type of fatty liver disease. You will either receive HU6 or a placebo to see how it affects your liver health.
Chandler, ArizonaAges 30 years+ - NCT06739330Recruiting
Thyroid function and fatty liver disease study
This study looks at how your thyroid might be linked to fatty liver disease (MAFLD). It aims to help researchers understand if thyroid problems play a role in this condition, which could lead to better treatments.
Tanta, El-GharbiaAges 18 years+ - NCT07145151RecruitingPhase 2
Studying UBT251 for MASH liver disease
This trial tests a new medication called UBT251 for people with MASH, a type of liver disease linked to weight and metabolism. It aims to see if the medicine can reduce liver damage and scarring.
Beijing, Beijing MunicipalityAges 18–75 - NCT07454252Recruiting
Study on biomarkers for bone, muscle, and energy health
This study looks at blood samples already collected from patients to find markers related to bone, muscle, and energy metabolism. It may help doctors better understand these processes and identify potential health issues.
Milan, ItalyAges 18 years+ - NCT06575400RecruitingPhase 1
Testing tolerance of BI 3804379 in healthy people and MASH patients
This study tests how well different doses of a new drug (BI 3804379) are tolerated. It is for healthy people and for patients with MASH (a type of fatty liver disease) who have advanced liver scarring.
EdegemAges 18–65 - NCT06561503Recruiting
Quality of life in inherited metabolic diseases
This study looks at how certain rare metabolic disorders affect quality of life. Researchers at Sohag University Hospital want to understand the daily challenges patients face, so they can improve care and support.
SohagAges 1 day–18 years - NCT07330830Recruiting
Genetics and fatty liver disease in Caribbean and Indian Ocean populations
This study looks at how a specific gene (PNPLA3) might affect non-alcoholic fatty liver disease (MASLD) in people from Guadeloupe, French Guiana, and Réunion Island. It aims to understand genetic differences that could explain why some people get the disease.
CayenneAges 18 years+
Hear when a new Metabolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for metabolism?
- Yes. Clin2 currently lists 1,077 recruiting metabolism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a metabolism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a metabolism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.